Preclinical
APEIRON Biologics AG announced that it will present preclinical data for its clinical stage project APN401 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 26-30 October 2019 in Boston, MA, USA.
Preclinical data shows SHP2 inhibitor enhances activity of osimertinib in EGFR-driven tumor xenografts
Successful completion of the preclinical program has provided strong scientific proof that the GaRP dietary supplement has the potential to be game changing
The Goal Is To Develop Novel Pre-clinical Programmes For High Unmet Medical Need Conditions For Women
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.
Sareum Holdings plc is pleased to announce that it will present new preclinical data from its SDC-1802 TYK2/JAK1 inhibitor cancer research programme at the American Association for Cancer Research National Cancer Institute European Organisation for Research and Treatment of Cancer International Conference, to be held 26-30 October 2019 in Boston, USA.
APEIRON Biologics AG announced that it will present its development program and data from ongoing preclinical studies of APN401.
Nordic Nanovector ASA (OSE: NANO) will host an R&D day in Oslo.
Memo Therapeutics announced that it is entering preclinical development with its first drug candidate an anti-BKV antibody isolated from humans for the treatment of BK virus infection after renal transplantation.
PRESS RELEASES